October 15, 2018 – Toronto, Ontario – Matica Enterprises Inc. (MMJ–CSE) (39N – Frankfurt) (MQPXF – OTC PINK) (“Matica” or the “Company”) is pleased to announce that RoyalMax Biotechnology Canada Inc. (“RoyalMax”) has been granted a license to cultivate cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) for the production facility in Dorval, Quebec. RoyalMax has one of the twelve licenses now granted in the province of Quebec.
Matica Enterprises CEO, Boris Ziger states, “At this juncture I would like to thank all of those who made this important milestone possible. The hard work and dedication that went into making our dream a reality was nothing short of monumental. I also want to thank all of our shareholders and stakeholders for the unwavering faith they have showed us. As amazing a feeling as it is to have achieved our goal, we all know that this is really just the beginning. Our vision for Matica and RoyalMax is just now ready to unfold as we are committed to a larger, multifaceted company built on this strong foundation. We can now implement our growth strategy which includes research into new strains and proprietary products, and larger facilities which will grow exceptional product for our consumers.”
For more information on Matica please visit the website at: www.maticaenterprises.com.
On behalf of the Board of Directors
MATICA ENTERPRISES INC.
Boris Ziger, CEO & Chairman
For further information, please contact Boris Ziger, Chief Executive Officer, at:
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information, identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.
The CSE has not reviewed, approved or disapproved the content of this press release.